Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1525 73 |
Ultima descărcare din IBN: 2024-02-23 22:07 |
SM ISO690:2012 GLADÎŞ, Valentina, CORCIMARU, Ion, ROBU, Maria, CHELEA, Iurie, PLASCHEVICI, Irina. Caracteristica sindromului de diferenţiere în tratamentul pacienţilor cu leucemie acută promielocitară. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2012, nr. 3(13), pp. 313-316. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 3(13) / 2012 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 313-316 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Characteristics differentiation syndrome in treatment
of patients with acute promyelocytic leukemia
It was examined clinical features, incidence and prognostic factors of differentiation syndrome (DS) in induction therapy in 83 patients with acute promyelocytic leukemia with age from 5 to 71 years ( female-55, male-28). Severe DS was registered in 9 (10,8%) patients, moderate DS - 23 (27,7%) cases. In most causes (71,9%) there were registered late DS. WBC count greater than 5,0x109/l was appeared as unfavorable factor of developing DS.
Key words: . differentiation syndrome, acute promyelocytic leukemia. |
||||||
Cuvinte-cheie sindrom de diferenţiere, leucemie acută promielocitară |
||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Gladîş, V.V.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Corcimaru, I.T.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Robu, M.V.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Chelea, I.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Plaschevici, I.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='ro'>Caracteristica sindromului de diferenţiere în tratamentul pacienţilor cu leucemie acută promielocitară</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2012</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1857-1719</relatedIdentifier> <subjects> <subject>sindrom de diferenţiere</subject> <subject>leucemie acută promielocitară</subject> </subjects> <dates> <date dateType='Issued'>2012-06-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'>Characteristics differentiation syndrome in treatment of patients with acute promyelocytic leukemia It was examined clinical features, incidence and prognostic factors of differentiation syndrome (DS) in induction therapy in 83 patients with acute promyelocytic leukemia with age from 5 to 71 years ( female-55, male-28). Severe DS was registered in 9 (10,8%) patients, moderate DS - 23 (27,7%) cases. In most causes (71,9%) there were registered late DS. WBC count greater than 5,0x109/l was appeared as unfavorable factor of developing DS. Key words: . differentiation syndrome, acute promyelocytic leukemia.</description> <description xml:lang='ro' descriptionType='Abstract'>A fost studiată caracteristica clinică, frecvenţa şi factorii prognostici a sindromului de diferenţiere ( SD) în perioada de inducere a remisiunii la 83 pacienţi cu leucemie acută promielocitară în vîrsta de la 5 pînă la 71 ani ( femei-55, bărbaţi-28). La 32 ( 38,5%) patienţi s-a dezvoltat SD. Forma gravă a SD a fost înregistrată la 9 (10,8%) bolnavi, forma de gravitate medie –în 23 ( 27,7%) cazuri. În majoritatea cazurilor (71,9%) s-a inregistrat SD tardiv. Numărul de leucocite mai mare de 5,0x 10 9/l constituie un factor prognostic nefavorabil pentru dezvoltarea SD.</description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>